Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
-
Upload
violet-pope -
Category
Documents
-
view
26 -
download
0
description
Transcript of Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
![Page 1: Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63](https://reader036.fdocuments.net/reader036/viewer/2022082611/568132a2550346895d994437/html5/thumbnails/1.jpg)
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
![Page 2: Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63](https://reader036.fdocuments.net/reader036/viewer/2022082611/568132a2550346895d994437/html5/thumbnails/2.jpg)
Characteristics of selected major statin trials
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
![Page 3: Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63](https://reader036.fdocuments.net/reader036/viewer/2022082611/568132a2550346895d994437/html5/thumbnails/3.jpg)
Updated meta-analysis of major statin trials that assessed the effect of statins on fatal and non-fatal stroke
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
![Page 4: Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63](https://reader036.fdocuments.net/reader036/viewer/2022082611/568132a2550346895d994437/html5/thumbnails/4.jpg)
Updated meta-analysis of major statin trials that assessed the effect of statins on fatal stroke
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
![Page 5: Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63](https://reader036.fdocuments.net/reader036/viewer/2022082611/568132a2550346895d994437/html5/thumbnails/5.jpg)
Updated meta-analysis of major statin trials that assessed the effect of statins on haemorrhagic stroke
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
![Page 6: Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63](https://reader036.fdocuments.net/reader036/viewer/2022082611/568132a2550346895d994437/html5/thumbnails/6.jpg)
Association between reduction in LDL cholesterol concentration with stroke incidence among the major statins trials
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
![Page 7: Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63](https://reader036.fdocuments.net/reader036/viewer/2022082611/568132a2550346895d994437/html5/thumbnails/7.jpg)
Meta-analysis of statin trials that assessed the effect of intensive lipid-lowering therapy versus standard statin therapy on incidence
of fatal and non-fatal stroke and on major cardiovascular events
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63